Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
12 participants
OBSERVATIONAL
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Association Between Visceral Obesity and the Progression of Diabetic Nephropathy
NCT06563791
Body Fat Mass Association With Clinical Metabolic Profiles, Markers of Inflammation and Adipocytokines
NCT02799719
Accelerated Aging of the Cells of Visceral Adipose Tissue in Morbid Obese Subjects
NCT01525472
Effects of Intentional Weight Loss Interventions in Chronic Kidney Disease
NCT01180101
Collection of Human Tissue Samples From the Neck Region for Characterization of Its Molecular and Biochemical Signatures
NCT02274805
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication nephrectomy for kidney tumor
* Stadium T1a, T1b or T2 and M0 according to the TNM (Tumor Nodes Metastasis) classification of tumors
Exclusion Criteria
* Asian topic because of the difference threshold values used to characterize the metabolic syndrome in this population
* Diabetes type I or II due to a high score of renal interstitial fibrosis
* Infection with HIV (Human immunodeficiency virus)
* Partial nephrectomy (a part of the kidney on the side of the tumor is left in place)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nice
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-PP-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.